AAAAAA
Results: 1-25/33
Authors:
ADAMSKI H
LEGALL F
COINDRE JM
KERBRAT P
CHEVRANTBRETON J
Citation: H. Adamski et al., RECURRING ATYPICAL (PSEUDOSARCOMATOUS) CUTANEOUS FIBROUS HISTIOCYTOMA, EJD. European journal of dermatology, 8(2), 1998, pp. 122-124
Authors:
CURE H
KRAKOWSKI I
ADENIS A
TUBIANA N
KERBRAT P
ROCHE H
CHEVALLIER B
LENTZ MA
FUMOLEAU P
CHOLLET P
Citation: H. Cure et al., RESULTS OF A PHASE-II TRIAL WITH 2ND-LINE CYSTEMUSTINE AT 60 MG M(2) IN ADVANCED SOFT-TISSUE SARCOMA - A TRIAL OF THE EORTC EARLY CLINICAL-STUDIES GROUP/, European journal of cancer, 34(3), 1998, pp. 422-423
Authors:
HERON JF
JOLY F
KERBRAT P
CHAUVERGNE J
MAYER F
WEBER B
CHINETCHARROT P
CROUET H
GOUPIL A
LESECH JM
LEBRUNJEZEKOVA D
NAMER M
MARTIN C
GUASTALLA JP
LHOMME C
Citation: Jf. Heron et al., CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/, Annals of oncology, 9, 1998, pp. 315-315
Authors:
BOUCHER E
CARSIN A
RAOUL JL
MARCHETTI C
JORAM F
KERBRAT P
Citation: E. Boucher et al., FATAL LIVER NECROSIS FOLLOWING TREATMENT OF HEPATOCELLULAR-CARCINOMA BY PERCUTANEOUS ETHANOL INJECTION, Gastroenterologie clinique et biologique, 22(4), 1998, pp. 459-461
Authors:
RAOUL JL
BOUCHER E
GOUDIER MJ
GESTIN H
KERBRAT P
Citation: Jl. Raoul et al., UMBILICAL METASTASIS OF HEPATOCELLULAR-CA RCINOMA, Gastroenterologie clinique et biologique, 22(4), 1998, pp. 470-471
Authors:
KERBRAT P
NAMER M
Citation: P. Kerbrat et M. Namer, ADJUVANT TREATMENTS OF SURGICAL BREAST-CANCER, Bulletin du cancer, 85(6), 1998, pp. 589-590
SHORT-TERM VS LIFELONG ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER (EBC) - A RANDOMIZED TRIAL (TAM-01)
Authors:
DELOZIER T
SPIELMANN M
MACELESECH J
JANVIER M
ASSELAIN B
JULIEN JP
WEBER B
MAURIAC L
PETIT JC
KERBRAT P
Citation: T. Delozier et al., SHORT-TERM VS LIFELONG ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER (EBC) - A RANDOMIZED TRIAL (TAM-01), European journal of cancer, 33, 1997, pp. 343-343
Authors:
FUMOLEAU P
CHAUVIN F
NAMER M
BUGAT R
TUBIANAHULIN M
GUASTALLA JP
DELOZIER T
KERBRAT P
DEVAUX Y
FILLEUL A
Citation: P. Fumoleau et al., ADJUVANT CHEMOTHERAPY WITH AC VERSUS HIGH-DOSE MITOXANTRONE, CYCLOPHOSPHAMIDE (MC), FILGRASTRIM IN OPERABLE BREAST-CANCER INVOLVING 10 OR MORE AXILLARY LYMPH-NODES - 3 YEARS FOLLOW-UP RESULTS, European journal of cancer, 33, 1997, pp. 351-351
Authors:
MARCHETTI C
CARSIN A
SOREL L
KERBRAT P
FLEURY P
BOURGUET P
Citation: C. Marchetti et al., MICROCALCIFICATIONS IN AXILLARY LYMPH-NOD ES REVEALING BREAST-CANCER, Journal de radiologie, 78(6), 1997, pp. 457-459
Authors:
MONCORGE R
GARNIER N
KERBRAT P
WYON C
BOREL C
Citation: R. Moncorge et al., SPECTROSCOPIC INVESTIGATION AND 2-MICRON LASER PERFORMANCE OF TM3-CRYSTALS(CAYALO4 SINGLE), Optics communications, 141(1-2), 1997, pp. 29-34
Authors:
KERBRAT P
LAGUERRE B
LEFEUVRE C
Citation: P. Kerbrat et al., COMMENTS ON ASCO RECOMMENDATIONS FOR POST TREATMENT FOLLOW-UP OF BREAST-CANCER PATIENTS, Bulletin du cancer, 84(10), 1997, pp. 991-992
Authors:
DELOZIER T
SWITSERS O
GENOT JY
OLLIVIER JM
HERY M
NAMER M
FRENAY M
KERBRAT P
JULIEN JP
NAJA A
JANVIER M
MACELESECH J
Citation: T. Delozier et al., LATE DELAYED ADJUVANT TAMOXIFEN IN EARLY BREAST-CANCER - RESULTS OF ACOOPERATIVE RANDOMIZED TRIAL, Bulletin du cancer, 84(1), 1997, pp. 25-30
Authors:
UROSEVIC V
CHOLLET P
ADENIS A
CHAUVERGNE J
FARGEOT P
ROCHE H
KERBRAT P
LENTZ MA
FUMOLEAU P
CHEVALLIER B
Citation: V. Urosevic et al., RESULTS OF A PHASE-II TRIAL WITH CYSTEMUSTINE IN ADVANCED MALIGNANT-MELANOMA - A TRIAL OF THE EORTC CLINICAL SCREENING GROUP, European journal of cancer, 32A(1), 1996, pp. 181-182
Authors:
FUMOLEAU P
CHEVALLIER B
KERBRAT P
KRAKOWSKI Y
MISSET JL
MAUGARDLOUBOUTIN C
DIERAS V
AZLI N
BOUGON N
RIVA A
ROCHE H
Citation: P. Fumoleau et al., A MULTICENTER PHASE-II STUDY OF THE EFFICACY AND SAFETY OF DOCETAXEL AS FIRST-LINE TREATMENT OF ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC, Annals of oncology, 7(2), 1996, pp. 165-171
Authors:
LHOMME C
KERBRAT P
LEJEUNE C
GUASTALLA JP
FUMOLEAU P
GOUPIL A
HERON JF
CASSIN MA
PRUVOT I
SOARES JA
CHAZARD M
Citation: C. Lhomme et al., CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY, Seminars in oncology, 23(5), 1996, pp. 48-54
Authors:
KHAYAT D
BANZET P
WEIL M
FUMOLEAU P
AVRIL MF
NAMER M
BONNETERRE J
KERBRAT P
BONERANDI JJ
BUGAT R
MONTCUQUET P
CUPISSOL D
LAUVIN R
VILMER C
BOAZIZ C
COUR V
BIZZARI JP
Citation: D. Khayat et al., FOLLOW-UP OF 153 MELANOMA EVALUABLE PATIENTS TREATED BY FOTEMUSTINE -PROGNOSIS FACTORS FOR RESPONSE AND SURVIVAL, Medicamentos de actualidad, 32, 1996, pp. 35-41
Authors:
DIERAS V
CHEVALLIER B
KERBRAT P
KRAKOWSKI I
ROCHE H
MISSET JL
LENTZ MA
AZLI N
MURAWSKY M
RIVA A
POUILLART P
FUMOLEAU P
Citation: V. Dieras et al., A MULTICENTER PHASE-II STUDY OF DOCETAXEL 75 MG M(-2) AS FIRST-LINE CHEMOTHERAPY FOR PATIENTS WITH ADVANCED BREAST-CANCER - REPORT OF THE CLINICAL SCREENING GROUP OF THE EORTC, British Journal of Cancer, 74(4), 1996, pp. 650-656
Authors:
BONNETERRE J
TUBIANAHULIN M
CHOLLET P
CHEVALLIER B
FUMOLEAU P
KERBRAT P
VIE B
KHAYAT D
TUBIANA N
LEJEUNE C
LEGRAND A
SOARES JA
PELLAECOSSET B
Citation: J. Bonneterre et al., TAXOL(R) (PACLITAXEL) 225 MG M(2) BY 3-HOUR INFUSION WITHOUT G-CSF ASA FIRST LINE THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)/, European journal of cancer, 31A, 1995, pp. 354-354
Authors:
HERON JF
LHOMME C
KERBRAT P
MAYER F
CHEVALLIER B
GOUPIL A
VENNIN P
LEBRUN D
CHAUVERGNE J
AYME Y
NAMER M
Citation: Jf. Heron et al., HIGH-DOSE CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH BULKY RESIDUAL DISEASE, European journal of cancer, 31A, 1995, pp. 503-503
Authors:
LHOMME C
GUASTALLA JP
DAUPLAT J
FERRERO JM
OBERLING F
VENNIN P
POUILLART P
FUMOLEAU P
KERBRAT P
TUBIANA N
HERON JF
BUGAT R
BACHELOT T
SCHREINEROVA M
FLEURY J
NAMER M
DUFOUR P
DIERAS V
SOLARMICHEL P
PRUVOT I
CHANEZ MA
GARET F
CHAZARD M
PELLAECOSSET B
Citation: C. Lhomme et al., A PHASE-II STUDY OF TAXOL(R) (T) (PACLITAXEL) OVER 3 HOURS (H) IN 192PLATINUM PRETREATED PATIENTS (PTS) FOR OVARIAN-CARCINOMA (OC), European journal of cancer, 31A, 1995, pp. 507-507
Authors:
CHAUVERGNE J
KERBRAT P
ADENIS A
CHOLLET P
FARGEOT P
PUJADELAURAINE E
DIERAS V
MADELMONT JC
LENTZ MA
TOULOUSE C
CHEVALLIER B
Citation: J. Chauvergne et al., PHASE-II STUDY OF CYSTEMUSTINE IN ADVANCED RENAL-CANCER, European journal of cancer, 31A(1), 1995, pp. 130-131
Authors:
GUASTALLA JP
KERBRAT P
Citation: Jp. Guastalla et P. Kerbrat, WHAT IS THE APPROPRIATE FOLLOW-UP FOR BRE AST-CANCER PATIENTS, La Presse medicale, 24(31), 1995, pp. 1415-1417
Authors:
CHEVALLIER B
CHOLLET P
MERROUCHE Y
ROCHE H
FUMOLEAU P
KERBRAT P
GENOT Y
FARGEOT P
OLIVIER JP
FIZAMES C
CLAVEL M
YVER A
CHABERNAUD VC
Citation: B. Chevallier et al., LENOGRASTIM PREVENTS MORBIDITY FROM INTENSIVE INDUCTION CHEMOTHERAPY IN THE TREATMENT OF INFLAMMATORY BREAST-CANCER, Journal of clinical oncology, 13(7), 1995, pp. 1564-1571
Authors:
CHEVALLIER B
FUMOLEAU P
KERBRAT P
DIERAS V
ROCHE H
KRAKOWSKI I
AZLI N
BAYSSAS M
LENTZ MA
VANGLABBEKE M
Citation: B. Chevallier et al., DOCETAXEL IS A MAJOR CYTOTOXIC DRUG FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE CLINICAL SCREENING COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER, Journal of clinical oncology, 13(2), 1995, pp. 314-322
Authors:
FUMOLEAU P
CHEVALLIER B
KERBRAT P
DIERAS V
AZLI N
BAYSSAS M
VANGLABBEKE M
Citation: P. Fumoleau et al., CURRENT STATUS OF TAXOTERE(R) (DOCETAXEL) AS A NEW TREATMENT IN BREAST-CANCER, Breast cancer research and treatment, 33(1), 1995, pp. 39-46